BlackRock Health Sciences Trust (NYSE:BME) Stock Jumps 0.5% – Time to Buy?

BlackRock Health Sciences Trust (NYSE:BME) was up 0.5% on Tuesday. The stock traded as high as $47.93 and last traded at $47.9420. 53,788 shares were traded during trading, an increase of 21% from the average session volume of 44,553 shares. The stock had previously closed at $47.69.

BlackRock Health Sciences Trust Stock Up 0.5%

The business has a 50 day simple moving average of $45.02 and a 200-day simple moving average of $42.29.

BlackRock Health Sciences Trust Dividend Announcement

The business also recently announced a monthly dividend, which will be paid on Tuesday, December 22nd. Investors of record on Friday, December 11th will be given a $0.2621 dividend. The ex-dividend date of this dividend is Friday, December 11th. This represents a $3.15 annualized dividend and a dividend yield of 6.6%.

Institutional Trading of BlackRock Health Sciences Trust

Several institutional investors have recently made changes to their positions in BME. Halbert Hargrove Global Advisors LLC lifted its position in BlackRock Health Sciences Trust by 75.0% in the 3rd quarter. Halbert Hargrove Global Advisors LLC now owns 1,050 shares of the company’s stock valued at $46,000 after purchasing an additional 450 shares during the last quarter. Root Financial Partners LLC acquired a new position in shares of BlackRock Health Sciences Trust during the 3rd quarter valued at $26,000. Rothschild Investment LLC acquired a new stake in shares of BlackRock Health Sciences Trust in the third quarter valued at $42,000. Northwestern Mutual Wealth Management Co. acquired a new position in BlackRock Health Sciences Trust during the second quarter worth about $69,000. Finally, Jacobi Capital Management LLC bought a new stake in BlackRock Health Sciences Trust in the third quarter worth about $108,000.

About BlackRock Health Sciences Trust

BlackRock Health Sciences Trust (NYSE:BME) is a closed-end investment company managed by BlackRock Advisors. The fund seeks to provide total return through a combination of current income and capital appreciation by investing primarily in the equity securities of companies involved in the health sciences sector. Its portfolio may include pharmaceutical, biotechnology, medical device, health care services, life sciences tools and diagnostics, and other related businesses. The fund can invest across a range of company sizes and may pursue opportunities in both U.S. and international markets, giving investors access to multiple segments of the global health care industry through a single investment vehicle.